Sutinen J - Search Results

Year	Number of Results
1981	1
1997	1
1998	1
1999	1
2002	1
2003	4
2004	5
2005	4
2006	1
2007	3
2008	4
2009	3
2010	4
2011	2
2012	2
2013	1
2014	2
2015	2
2016	4
2017	5
2018	5
2019	2
2020	3
2021	2
2022	3
2023	2
2024	1

1

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.

2

A qualitative study to identify thematic areas for HIV related patient-reported outcome measures (PROM) and patient-reported experience measures (PREM).

Lohiniva AL, Isosomppi S, Pasanen S, Sutinen J. Lohiniva AL, et al. Among authors: sutinen j. J Patient Rep Outcomes. 2023 May 1;7(1):41. doi: 10.1186/s41687-023-00582-y. J Patient Rep Outcomes. 2023. PMID: 37126134 Free PMC article.

3

Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study.

Hanttu AM, Pekkala S, Satokari R, Hartikainen AK, Arkkila P, Pietiläinen KH, Sutinen JP. Hanttu AM, et al. Among authors: sutinen jp. AIDS. 2023 Feb 1;37(2):323-332. doi: 10.1097/QAD.0000000000003419. Epub 2022 Nov 10. AIDS. 2023. PMID: 36541643 Clinical Trial.

4

Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain.

Kauppinen KJ, Aho I, Sutinen J. Kauppinen KJ, et al. Among authors: sutinen j. AIDS. 2022 Aug 1;36(10):1337-1344. doi: 10.1097/QAD.0000000000003245. Epub 2022 Jun 21. AIDS. 2022. PMID: 35727143

5

Comorbid conditions as risk factors for West Nile neuroinvasive disease in Ontario, Canada: a population-based cohort study.

Sutinen J, Fell DB, Sander B, Kulkarni MA. Sutinen J, et al. Epidemiol Infect. 2022 May 11;150:e103. doi: 10.1017/S0950268822000887. Epidemiol Infect. 2022. PMID: 35543409 Free PMC article.

6

Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir.

Hanttu A, Vuoti S, Kivelä P, Arkkila P, Lundbom N, Hakkarainen A, Lundbom J, Lehtimäki T, Viskari H, Lehtinen V, Pietiläinen KH, Sutinen J. Hanttu A, et al. Among authors: sutinen j. AIDS Patient Care STDS. 2021 Sep;35(9):335-341. doi: 10.1089/apc.2021.0106. AIDS Patient Care STDS. 2021. PMID: 34524919

7

Prevalence of obesity and disturbances in glucose homeostasis in HIV-infected subjects and general population - missed diagnoses of diabetes?

Hanttu A, Kauppinen KJ, Kivelä P, Ollgren J, Jousilahti P, Liitsola K, Koponen P, Sutinen J. Hanttu A, et al. Among authors: sutinen j. HIV Med. 2021 Apr;22(4):244-253. doi: 10.1111/hiv.13009. Epub 2020 Nov 9. HIV Med. 2021. PMID: 33169536 Free PMC article.

8

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting.

Kauppinen KJ, Kivelä P, Sutinen J. Kauppinen KJ, et al. Among authors: sutinen j. AIDS Patient Care STDS. 2019 Dec;33(12):500-506. doi: 10.1089/apc.2019.0236. Epub 2019 Nov 19. AIDS Patient Care STDS. 2019. PMID: 31742421

9

Reply to Krahn and Sebastiani.

Yki-Järvinen H, Lallukka-Brück S, Sutinen J. Yki-Järvinen H, et al. Among authors: sutinen j. Clin Infect Dis. 2020 Jun 24;71(1):245. doi: 10.1093/cid/ciz930. Clin Infect Dis. 2020. PMID: 31538645 No abstract available.

10

Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study.

Lallukka-Brück S, Isokuortti E, Luukkonen PK, Hakkarainen A, Lundbom N, Sutinen J, Yki-Järvinen H. Lallukka-Brück S, et al. Among authors: sutinen j. Clin Infect Dis. 2020 Apr 10;70(8):1708-1716. doi: 10.1093/cid/ciz435. Clin Infect Dis. 2020. PMID: 31131845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year